Get Started

AZTR

AMEX Azitra Inc
Oct 31, 2026 · 12:26 PM ET EOD Market Closed

$0.7692 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.7692, $0.0208 below the day’s high of $0.7900

YTD change
-70.95%
vs 20-day SMA
-41.94%
vs 200-day SMA
-60.11%

Price ranges

Previous day
$0.6511 $0.7900
open $0.7120 close $0.7692
+$0.0572 (+8.03%)
Today
$0.6511 $0.7900
$0.7692
Past week
$0.5180 $2.1299
from $1.1760 now $0.7692
-$0.4068 (-34.59%)
Past month
$0.5180 $2.1299
from $1.7100 now $0.7692
-$0.9408 (-55.02%)
This year
$0.0518 $2.6480
from $2.6480 now $0.7692
-$1.8788 (-70.95%)

Price & Performance

+0.52 (+211.04%) / 6M

$-0.0452$0.5188$1.08$1.65May 1Jul 28Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 100.0% away from all-time highs of $10,349.6000
  • AZTR is down 71% since the beginning of the year
  • AZTR is down 87% over the past 12 months
  • AZTR is down 55% over the past 1 month
  • 0% of all AZTR investors are betting against AZTR
  • Number of investors short AZTR has gone down 18% versus last month

AZTR reads poor: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +47.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.7
Earnings momentum -750.0% Quarterly EPS growth
Quarterly change -750.0%

Valuation

P/E ratio N/A
Enterprise value $-4856500.0
Beta -1.62

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$6.7M
Debt$410.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $4.7M

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.